EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study

Solveig Vieluf iD, Sasagu Tomioka iD, Bo Zhang, Vaishnav Krishnan, William J Bosl, Todd Grinnell, Tobias Loddenkemper

Epilepsia · 2025-11 · 66 (11) · 4259-4271

DOI: 10.1111/epi.18550 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 12.07.2025. Verfasst von Solveig Vieluf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epilepsy and Clinical Neurophysiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Seizures, Drug Resistant Epilepsy, Diaries as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Sumitomo Pharma America, Inc. (formerly Sunovion Pharmaceuticals Inc.), American Epilepsy Society, Epilepsy Reserach Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In patients with intractable epilepsy, accurate diaries of seizure occurrence and timing can substantially inform management. Wearable devices that provide confirmation of seizure occurrence complement such diaries, which are frequently incomplete and/or inaccurate. Here, we combined seizure diaries and longitudinally deployed wrist‐worn device recordings to evaluate whether wearable recordings contain information that can discriminate between days containing seizure‐related activity and those without.

Methods

Patients with focal seizures were prospectively enrolled in a clinical trial to test the effectiveness of eslicarbazepine acetate as an adjunct to levetiracetam or lamotrigine (phase IV clinical trial NCT03116828). One hundred two patients maintained a seizure diary and wore a biosensor for >30 weeks. Based on diaries, we labeled days as either “seizure” versus “no‐seizure” or “preseizure” versus “no‐preseizure.” We compared patterns obtained by harmonic 24‐h modeling between conditions. Best‐ranking wearable markers and seizure diary variables were fed into a fully connected neural network, with several hidden layers and depth as hyperparameters that classified between seizure day conditions.

Results

The final sample contained 70 patients (median age = 42.5 years, 43 female) with 5437 recorded patient‐days, including 557 seizure days and 537 preseizure days. Twenty‐four‐hour patterns in electrodermal activity and accelerometry differentiated no‐seizure versus seizure days, as well as no‐preseizure versus preseizure days ( p < .01). Classification between no‐seizure and seizure days (weighted F1 = .81, sensitivity = .82, specificity = .67) as well as between no‐preseizure and preseizure days (weighted F1 = .82, sensitivity = .80, specificity = .66) revealed good performance. Significance Wearable data capture seizure‐related differences with daily resolution, differentiating between days with lower and higher seizure susceptibility. Combining diary‐based clinical and wearable data bears the potential for developing a dynamic seizure detection and prediction system with daily resolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wearable Electronic DevicesSeizuresDrug Resistant EpilepsyDiaries as TopicHumansMaleFemaleLongitudinal StudiesAdultMiddle AgedAnticonvulsantsYoung AdultAdolescentLamotrigineLevetiracetamProspective Studies

Stichwörter der Autor:innen

24‐h patternbiosensorseslicarbazepine acetateseizure biomarkerseizure forecasting

Substanzen

AnticonvulsantsLamotrigineLevetiracetam

Autor:innen und Institutionen

  • Division of Epilepsy and Clinical Neurophysiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Medicine I, Ludwig Maximilian University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
  • DZHK (German Centre for Cardiovascular Research), partner site, Munich Heart Alliance, Munich, Germany.
  • Sumitomo Pharma America, Inc., Marlborough, Massachusetts, USA.
  • Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Departments of Neurology, Neuroscience, and Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Solveig Vieluf, Sasagu Tomioka

Förderung

  • Sumitomo Pharma America, Inc. (formerly Sunovion Pharmaceuticals Inc.)
  • American Epilepsy Society
  • Epilepsy Reserach Fund

Zitieren

APA

Vieluf, S., Tomioka, S., Zhang, B., Krishnan, V., Bosl, W. J., Grinnell, T., & Loddenkemper, T. (2025). Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study. Epilepsia, 66(11), 4259-4271. https://doi.org/10.1111/epi.18550

Vancouver

Vieluf S, Tomioka S, Zhang B, Krishnan V, Bosl WJ, Grinnell T, et al. Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study. Epilepsia. 2025;66(11):4259-4271. doi:10.1111/epi.18550

BibTeX
@article{Vieluf2025,
  author = {Vieluf, Solveig and Tomioka, Sasagu and Zhang, Bo and Krishnan, Vaishnav and Bosl, William J and Grinnell, Todd and Loddenkemper, Tobias},
  title = {Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {11},
  pages = {4259--4271},
  doi = {10.1111/epi.18550}
}
Kostenlos starten →